Target intelligence / Profile preview

Gut Ecosystem and Host Immune System

Molecular classification
Other
01

Overview

The term "Gut Ecosystem and Host Immune System" encompasses the dynamic and reciprocal interactions between the gut microbiota—a complex community of microorganisms living in the gastrointestinal tract—and the host immune system[1][2][3][4]. The gut microbiota produces metabolites and antigens that can both directly and indirectly regulate local and systemic immune responses, including the maturation of immune cells, maintenance of mucosal barrier function, and secretion of immunoglobulins (such as IgA)[2][3][4][5][6]. Disruptions to this relationship (e.g., gut dysbiosis) are implicated in a range of diseases, including chronic inflammation, infections, diabetes, cardiovascular disorders, immune-mediated diseases, and some cancers[2][4]. This area is a key focus for interventions such as probiotics, dietary modulation, and fecal microbiota transplantation, but is not itself a molecular, cellular, or receptor-level target.

Other names
Microbiota-immune axisGut microbiome-immune system interaction
02

Mechanism of action

Modulation of microbial populations (antibiotics, probiotics); Enhancement/restoration of mucosal immunity (probiotics/prebiotics); Alteration of immune signaling by microbial metabolites (such as short-chain fatty acids); Suppression or activation of inflammation.

03

Biological functions

Immune responseInflammatory regulationMaintenance of gut homeostasisNutrient absorption and metabolismBarrier integrity (mucosal barrier function)
04

Disease associations

InflammationAutoimmune diseaseInfectionType 2 diabetesCardiovascular diseaseInflammatory bowel diseaseCancerNeurodegenerative diseases
05

Safety considerations

Off-target immune modulation (risk of excessive inflammation or immunodeficiency)Gut dysbiosis leading to opportunistic infections or exacerbation of inflammatory diseasesTransfer of pathogenic organisms (in fecal microbiota transplantation)Antibiotic resistance
06

Interacting drugs

Probiotics

4 more in the full profile.

07

Biomarkers

Microbiome composition and diversity (16S rRNA sequencing)Levels of short-chain fatty acids (SCFAs)Mucosal IgA concentrationsInflammatory cytokines (e.g., IL-6, TNF-α)Gut permeability indicators (such as zonulin)

Beyond the preview

Go deeper on Gut Ecosystem and Host Immune System.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut Ecosystem and Host Immune System.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call